Summary
The relationship between the antidepressant effect of the tricyclic antidepressants and their plasma concentrations was reviewed. Logistic regression was utilised as an analytical tool to facilitate the evaluation. The currently available literature allowed the construction of 4 tricyclic data sets of sufficient size to warrant statistical analysis. Inspection of the distribution of the data and the logistic regression analyses resulted in several conclusions regarding the existence of ‘therapeutic windows’ for these drugs. Firstly, no relationship between amitriptyline plasma concentrations and therapeutic response was apparent. Secondly, curvilinear relationships were apparent for 2 of the other tricyclic antidepressants studied. The currently recommended therapeutic range of 60 to 150 µg/L for nortriptyline was found to be the range most likely to produce a positive antidepressant effect. Desipramine concentrations between 108 and 158 µg/L were most commonly associated with beneficial therapeutic responses. Finally, a linear relationship was noted for Imipramine in which an Imipramine therapeutic plasma concentration threshold of 244 εg/L and above was most commonly associated with a beneficial response to the drug.
Similar content being viewed by others
References
American Psychiatric Association. Diagnostic and statistical manual of Mental Disorders, 3rd ed., American Psychiatric Association, Washington, D.C., 1980
Asberg M, Kragh-Sorensen P, Mindham RHS, Tuck JR. International reliability and communicability of a rating scale for depression. Psychological Medicine 3: 458–465, 1973
Braithwaite RA, Goulding R, Theano G, Bailey J, Coppen A. Plasma concentration of amitriptyline and clinical response. Lancet 1: 1297–1300, 1972
Breyer-Pfaff U, Gaertner JH, Giedke H. Plasma levels, psychophysiological variables, and clinical response to amitriptyline. Psychiatry Research 6: 223–234, 1982b
Breyer-Pfaff U, Gaertner HJ, Krueter F, et al. Antidepressive effect and pharmacokinetics of amitriptyline with consideration of unbound drug and 10-hydroxynortriptyline plasma levels. Psychopharmacology 76: 240–244, 1982a
Brunswick DJ, Amsterdam JD, Potter L, Caroff S, Rickels K. Relationship between tricyclic antidepressant plasma levels and clinical response in patients treated with desipramine or doxepin. Acta Psychiatrica Scandinavica 67: 371–377, 1983
Burrows GD, Davies B, Scoggins BA. Plasma concentration of nortriptyline and clinical response in depressive illness. Lancet 2: 619–623, 1972
Costa D, Predescu V, Visan-Ionescu I, Ciurezu T. Endogenous depression and Imipramine levels in the blood. Psychopharmacology 70: 291–294, 1980
Dixon WJ, Brown MB, Engelman L, Frane JW, Hill MA, et al. BMDP Statistical Software, University of California Press, Berkeley, 1983
Feighner JP, Robins E, Guze SB, Woodruff RA, Winokur G, et al. Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry 26: 57–63, 1972
Glassman AH (Chairman). Tricyclic antidepressants: blood level measurements and clinical outcome: an APA task force report. American Journal of Psychiatry 142: 155–162, 1985
Gram LF, Reisby N, Ibsen I, Nagy A, Dencker S, et al. Plasma levels and antidepressive effect of Imipramine. Clinical Pharmacology and Therapeutics 19: 318–324, 1975
Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 23: 56–62, 1960
Hrdina PD, Lapierre YD. Clinical response, plasma levels and pharmacokinetics of desipramine in depressed in-patients. Progress in Neuro-Psychopharmacology 4: 591–600, 1981
Kragh-Sorensen P, Asberg M, Eggert-Hansen C. Plasma nortriptyline levels in endogenous depression. Lancet 1: 113–115, 1973
Kragh-Sorensen P, Hansen CE, Baastrup PC, Hvidberg EF. Self-inhibiting action of nortriptyline’s antidepressive effect at high plasma levels. Psychopharmacologia (Berlin) 45: 305–312, 1976
Mendlewicz J, Linkowski P, Rees JA. A double-blind comparison of dothiepin and amitriptyline in patients with primary affective disorder: serum levels and clinical response. British Journal of Psychiatry 136: 154–160, 1980
Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134: 382–389, 1979
Montgomery S, Braithwaite R, Dawling S, McAuley R. High plasma nortriptyline levels in the treatment of depression. Clinical Pharmacology and Therapeutics 23: 309–314, 1978
Murphy GE, Simons AD, Wetzel RD. Plasma nortriptyline and clinical response in depression. Journal of Affective Disorders 9: 123–129, 1985
Nelson JC, Jatlow P, Mazure C. Desipramine plasma concentration and response in elderly melancholic patients. Journal of Clinical Psychopharmacology 5: 217–220, 1985
Perry PJ, Browne JL, Alexander B, Pfohl BM, Dunner FJ, et al. Relationship of free nortriptyline levels to therapeutic response. Acta Psychiatrica Scandinavica 72: 120–125, 1985
Reisby N, Gram LF, Bech P, Nagy A, Petersen GO, et al. Imipramine: clinical effects and pharmacokinetic variability. Psychopharmacology 54: 263–272, 1977
Robinson DS, Cooper TB, Ravaris CL, Ives JO, Nies A, et al. Plasma tricyclic drug levels in amitriptyline-treated depressed patients. Psychopharmacology 63: 223–231, 1979
Spitzer RL, Endicott J, Robins E. Research diagnostic criteria. Archives of General Psychiatry 35: 773–782, 1978
Stewart JW, Quitkin F, Fyer A, Rifkin A, McGrath P, et al. Efficacy of desipramine in endogenomorphically depressed patients. Journal of Affective Disorders 2: 165–176, 1980
Turner RD, Coryell WH, Sherman A. Desipramine plasma levels and clinical response: evidence for a curvilinear relationship. Journal of Clinical Psychopharmacology 7: 138–142, 1987
Zeigler VE, Clayton PJ, Taylor JR, Co BT. Biggs JT. Nortriptyline plasma levels and therapeutic response. Clinical Pharmacology and Therapeutics 20: 458–463, 1977
Zeigler VE, Co BT, Taylor JR, Clayton PJ, Biggs JT. Amitriptyline plasma levels and therapeutic response. Clinical Pharmacology and Therapeutics 19: 795–801, 1976
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Perry, P.J., Pfohl, B.M. & Holstad, S.G. The Relationship Between Antidepressant Response and Tricyclic Antidepressant Plasma Concentrations. Clin-Pharmacokinet 13, 381–392 (1987). https://doi.org/10.2165/00003088-198713060-00003
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003088-198713060-00003